Brent Warner
Geen lopende functies
Vermogen: 1 M $ op 31-05-2024
Profiel
Brent Warner served as Vice President-Gene Therapy & Rare Disease at Novartis Pharmaceuticals Canada, Inc. from 2019 to 2022.
He then became President-Gene Therapy at Poseida Therapeutics, Inc. from 2022 to 2024.
Mr. Warner obtained an undergraduate degree and an MBA from Northwood University (Michigan).
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
01-03-2024 | 419 040 ( 0.43% ) | 1 M $ | 31-05-2024 |
Eerdere bekende functies van Brent Warner
Bedrijven | Functie | Einde |
---|---|---|
POSEIDA THERAPEUTICS, INC. | Corporate Officer/Principal | 01-04-2024 |
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Corporate Officer/Principal | 01-02-2022 |
Opleiding van Brent Warner
Northwood University (Michigan) | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
POSEIDA THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Novartis Pharmaceuticals Canada, Inc.
Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Canada, Inc. manufactures chemicals and pharmaceuticals products. It provides solutions on patients suffering from a variety of major illnesses including cancer, cardiovascular diseases, Alzheimer's disease, age-related macular degeneration, organ transplantation, and osteoporosis. The company was founded in 1996 and is headquartered in Dorval, Canada. | Health Technology |